Erratum: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer (Oncogene (2012) 31 (4362-4371) DOI: 10.1038/onc.2011.600);Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer

Oncogene

Volumn 31, Issue 40, 2012, Pages 4362-4371

  Patrick, B A ^a   Jaiswal, A K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

20S proteasome; C EBP ; NQO1; p63; skin differentiation

Indexed keywords

BENZO[A]PYRENE; CCAAT ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN P63; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; GENE; GENE EXPRESSION; HETEROZYGOSITY; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; NQ01 GENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN CANCER; SKIN EPITHELIUM; STRESS; UPREGULATION; WESTERN BLOTTING;

MUS;

EID: 84867230539     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.476     Document Type: Erratum

References (26)

1. Adler J, Reuven N, Kahana C, Shaul Y. (2010). c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines C-Fos serum response kinetics. Mol Cell Biol 30: 3767-3778.
2. Ahn KS, Sethi G, Jain AK, Jaiswal AK, Aggarwal BB. (2006). Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J Biol Chem 281: 19798-19808.
3. Asher G, Loten J, Cohen B, Sachs L, Shaul Y. (2001). Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA 98: 1188-1193.
4. Asher G, Loten J, Sachs L, Kahana C, Shaul Y. (2002). Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci USA 99: 13125-13130.
5. Asher G, Tsvetkov P, Kahana C, Shaul Y. (2005). A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19: 316-321.
6. Garate M, Wong RPC, Campos EI, Wang Y, Gang Li. (2008). NAD(P)H:quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33ING1b. EMBO Rep 9: 576-581.
7. Gong X, Kole L, Iskander K, Jaiswal AK. (2007). NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53. Cancer Res 67: 5380-5388.
8. Higashikawa K, Yoneda S, Tobiume K, Taki M, Shigeishi H, Kamata N. (2007). Snail-induced down-regulation of deltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma. Cancer Res 67: 9207-9213.
9. Iskander K, Gaikwad A, Paquet M, Long DJ, Brayton C, Barrios R et al. (2005). Lower induction of p53 and decreased apoptosis in NQO1-null mice leads to increased sensitivity of chemical-induced carcinogenesis. Cancer Res 65: 2054-2058.
10. Jaiswal AK, Bell DW, Radjendirane V, Testa JR. (1999). Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphism. Pharmacogenetics 9: 413-418.
11. Kaspar JW, Niture SK, Jaiswal AK. (2009). Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47: 1304-1309.
12. King KE, Weinberg WC. (2007). P63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis. Mol Carcinog 46: 716-724.
13. Long II DJ, Jaiswal AK. (2000). NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact 129: 99-112.
14. Long II DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. (2000). NAD(P)H:quinine oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene induced mouse skin carcinogenesis. Cancer Res 60: 5913-5915.
15. Long II DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. (2001). NAD(P)H:quinine oxidoreductase1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 93: 1166-1170.
16. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713.
17. Moll UM, Slade N. (2004). p63 and p73: roles in development and tumor formation. Mol Cancer Res 2: 371-386.
18. Patrick BA, Gong X, Jaiswal AK. (2011). Disruption of NAD(P)H:-quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemicalinduced skin cancer. Oncogene 30: 1098-1107.
19. Pietsch EC, Sykes SM, McMahon SB, Murphy SE. (2008). The p53 family and programmed cell death. Oncogene 27: 6507-6521.
20. Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ et al. (1998). Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273: 7382-7389.
21. Ross D. (2004). Quinone reductases multitasking in the metabolic world. Drug Metab Rev 36: 639-654.
22. Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D. (2001). Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol 59: 263-268.
23. Sigrist CJA, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, Bairoch A et al. (2010). PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res 38: 161-166.
24. Traver RD, Horikoshi T, Danenberg KD, Stadlbaur THW, Danenberg PV, Ross D et al. (1992). NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res 52: 797-802.
25. Vasiliou V, Ross D, Nebert DW. (2006). Update of the NAD(P) H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2: 329-335.
26. Zhang Y, Kensler TW, Cho C, Posner GH, Talalay P. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91: 3147-3150.